J. F. Camargo, H. Kulkarni, B. K. Agan, A. A. Gaitan, L. A. Beachy et al., Responsiveness of t cells to interleukin-7 is associated with higher cd4+ t cell counts in hiv-1positive individuals with highly active antiretroviral therapy-induced viral load suppression, The Journal of infectious diseases, vol.199, issue.12, pp.1872-1882, 2009.

A. Cappuccio, F. Castiglione, and B. Piccoli, Determination of the optimal therapeutic protocols in cancer immunotherapy, Mathematical biosciences, vol.209, issue.1, pp.1-13, 2007.

F. Castiglione and B. Piccoli, Optimal control in a model of dendritic cell transfection cancer immunotherapy, Bulletin of mathematical biology, vol.68, issue.2, pp.255-274, 2006.

F. Castiglione and B. Piccoli, Cancer immunotherapy, mathematical modeling and optimal control, Journal of theoretical Biology, vol.247, issue.4, pp.723-732, 2007.

O. Costa, F. Dufour, and A. Piunovskiy, Constrained and unconstrained optimal discounted control of piecewise deterministic markov processes, SIAM Journal on Control and Optimization, vol.54, issue.3, pp.1444-1474, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01412604

M. H. Davis, Piecewise-deterministic markov processes: A general class of non-diffusion stochastic models, Journal of the Royal Statistical Society Series B (Methodological, pp.353-388, 1984.

F. Dufour and H. Zhang, Numerical methods for simulation and optimization of piecewise deterministic markov processes, Bulletin of mathematical biology, vol.78, issue.10, pp.2091-2134, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01249897

A. Jarne, D. Commenges, L. Villain, M. Prague, Y. Lévy et al., Modeling cd4 + t cells dynamics in hiv-infected patients receiving repeated cycles of exogenous interleukin 7, The Annals of Applied Statistics, vol.11, issue.3, pp.1593-1616, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01579008

C. G. Lange and M. M. Lederman, Immune reconstitution with antiretroviral therapies in chronic hiv-1 infection, Journal of Antimicrobial Chemotherapy, vol.51, issue.1, pp.1-4, 2003.

M. Lavielle and F. Mentré, Estimation of population pharmacokinetic parameters of saquinavir in hiv patients with the monolix software, Journal of pharmacokinetics and pharmacodynamics, vol.34, issue.2, pp.229-249, 2007.
URL : https://hal.archives-ouvertes.fr/inserm-00156907

A. Leone, M. Rohankhedkar, A. Okoye, A. Legasse, M. K. Axthelm et al., Increased cd4+ t cell levels during il-7 administration of antiretroviral therapy-treated simian immunodeficiency virus-positive macaques are not dependent on strong proliferative responses, The Journal of Immunology, vol.185, issue.3, pp.1650-1659, 2010.

Y. Levy, C. Lacabaratz, L. Weiss, J. P. Viard, C. Goujard et al., Enhanced t cell recovery in hiv-1-infected adults through il-7 treatment, The Journal of clinical investigation, vol.119, issue.4, p.997, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00484803

C. Pasin,

Y. Levy, I. Sereti, G. Tambussi, J. Routy, J. Lelievre et al., Effects of recombinant human interleukin 7 on t-cell recovery and thymic output in hiv-infected patients receiving antiretroviral therapy: results of a phase i/iia randomized, placebocontrolled, multicenter study, Clinical Infectious Diseases, vol.55, issue.2, pp.291-300, 2012.

C. Lewden, G. Chêne, P. Morlat, F. Raffi, M. Dupon et al., Hiv-infected adults with a cd4 cell count greater than 500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.46, issue.1, pp.72-77, 2007.
URL : https://hal.archives-ouvertes.fr/inserm-00170726

C. L. Mackall, T. J. Fry, C. Bare, P. Morgan, A. Galbraith et al., Il-7 increases both thymic-dependent and thymic-independent t-cell regeneration after bone marrow transplantation, Blood, vol.97, issue.5, pp.1491-1497, 2001.

Y. Okamoto, D. C. Douek, R. D. Mcfarland, and R. A. Koup, Effects of exogenous interleukin-7 on human thymus function, Blood, vol.99, issue.8, pp.2851-2858, 2002.

F. Pappalardo, M. Pennisi, F. Castiglione, and S. Motta, Vaccine protocols optimization: in silico experiences, Biotechnology advances, vol.28, issue.1, pp.82-93, 2010.

M. Prague, D. Commenges, J. Guedj, J. Drylewicz, and R. Thiébaut, Nimrod: A program for inference via a normal approximation of the posterior in models with random effects based on ordinary differential equations, Computer methods and programs in biomedicine, vol.111, issue.2, pp.447-458, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00933752

I. Sereti, R. M. Dunham, J. Spritzler, E. Aga, M. A. Proschan et al., Il-7 administration drives t cell-cycle entry and expansion in hiv-1 infection, Blood, vol.113, issue.25, pp.6304-6314, 2009.

J. T. Tan, E. Dudl, E. Leroy, R. Murray, J. Sprent et al., Il-7 is critical for homeostatic proliferation and survival of naive t cells, Proceedings of the National Academy of Sciences, vol.98, issue.15, pp.8732-8737, 2001.

R. Thiebaut, J. Drylewicz, M. Prague, C. Lacabaratz, S. Beq et al., Quantifying and predicting the effect of exogenous interleukin-7 on cd4+ t cells in hiv-1 infection, PLoS Comput Biol, vol.10, issue.5, p.630, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01108204

R. Thiébaut, A. Jarne, J. P. Routy, I. Sereti, M. Fischl et al., Repeated cycles of recombinant human interleukin 7 in hiv-infected patients with low cd4 t-cell reconstitution on antiretroviral therapy: results of 2 phase ii multicenter studies, Clinical Infectious Diseases, vol.62, issue.9, pp.1178-1185, 2016.

A. T. Vella, S. Dow, T. A. Potter, J. Kappler, and P. Marrack, Cytokine-induced survival of activated t cells in vitro and in vivo, Proceedings of the National Academy of Sciences, vol.95, issue.7, pp.3810-3815, 1998.

, A Optimal control : application We defined the process describing the effect of IL-7 on CD4 + T lymphocytes dynamics by its characteristics ?, ? and Q, boundaries and possible actions in section 2.3. We also defined both gradual cost on the trajectory and impulse cost in that section, As we aim at Controlling IL-7 injections in HIV